This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
post featured image
Yesterday morning (12), the Brazilian Federal Government approved Law n. 14,338/22, which results from a bill of the Chamber of Deputies...
post featured image
For pharmaceutical companies, patent term extensions (PTEs) remain a fundamental means of compensating them for the erosion of the terms...
post featured image
It was really fantastic to attend the LSX World Congress 2022 in London on 10th and 11th May. So many excellent conversations to be had...
post featured image
On April 27th, Bill n° 1998/20 was approved by the Brazilian Chamber of Deputies of Brazil is currently awaiting approval by the Senate....
post featured image
This article was first published in Law360In recent years, the threat of cybersecurity attacks has evolved in the minds of the public and...
post featured image
On 7 April 2022, the Parliament passed the Act of 7 April 2022 on Medical Devices (the "Act"). It was signed by the President on 20...
post featured image
In this episode, DLA Piper managing partner Emilio Ragosa is joined by Kevin Sheridan, Joint Global Head of Healthcare Investment Banking...
post featured image
The annual report "Indicators of Access to Innovative Therapies in Europe (W.A.I.T. Indicator)", prepared by the consultancy firm Iqvia...
post featured image
Both the Clinical Trials Coordination Group (CTCG) and the Portuguese National Authority of Medicines and Health Products (INFARMED) have...
post featured image
On 29 March 2022, the Polish President signed the Act of 24 March 2022 amending the Act on Counteracting Drug Addiction (the "Act"). The...
post featured image
After the publication of the Code of conduct regulating the processing of personal data in the field of clinical trials and other...
post featured image
The Medicines & Healthcare products Regulatory Agency (MHRA) has announced a new supervisory scheme as part of its process for monitoring...
post featured image
We stand today on the threshold of almost unimaginable progress in defeating diseases that have ravaged humans for millennia. New...
post featured image
Along with the article about the ascension of FemTechs in the healthcare market, produced by the Life Sciences, Healthcare and Cannabis...
post featured image
Patent term extensions (PTEs) in Australia have been a hot topic over the past year.  On Friday, things got a lot hotter for patentees...
post featured image
This Wednesday (March 23, 2022), the Brazilian Health Regulatory Agency (ANVISA) approved a Collegiate Board Resolution (RDC) which...